YBX1 and breast carcinoma: For example, 2,4-dihydroxy-5-pyrimidinyl imidothiocarbamate (DPI) inhibits the malignant phenotype of breast cancer by preventing YBX1’s nuclear translocation and the activation of its downstream target genes [135].